Covenant Asset Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-33,196
Closed -$2.12M 171
2023
Q1
$2.12M Buy
33,196
+1,283
+4% +$83.7K 0.51% 62
2022
Q4
$1.55M Buy
31,913
+32
+0.1% +$2.01K 0.37% 76
2022
Q3
$2.25M Sell
31,881
-399
-1% -$34.1K 0.64% 55
2022
Q2
$2.29M Sell
32,280
-646
-2% -$41.6K 0.73% 51
2022
Q1
$2.63M Buy
32,926
+462
+1% +$34.4K 0.71% 43
2021
Q4
$2.96M Buy
32,464
+18,775
+137% +$2.01M 0.79% 40
2021
Q3
$1.76M Buy
+13,689
New +$1.92M 0.52% 53

Other funds holding STAA

Covenant Asset Management's STAA Position: Q2 2023 in Review

Covenant Asset Management sold out of STAAR Surgical (STAA) in Q2 2023, closing a stake of 33,196 shares — an estimated $2.12M sold.

Covenant Asset Management first reported a position in STAA in Q3 2021 and held it in 7 quarters. The position peaked at $2.96M in Q4 2021. 245 funds tracked by Wall St. Rank hold STAA as of Q2 2023.

  • Covenant Asset Management reported no remaining STAAR Surgical position as of Q2 2023 after selling out during the quarter.
  • Covenant Asset Management sold 33,196 STAAR Surgical shares in Q2 2023, an estimated $2.12M.
  • Covenant Asset Management first reported a position in STAAR Surgical in Q3 2021 and held it in 7 quarters.
  • Covenant Asset Management's STAAR Surgical position peaked at $2.96M in Q4 2021.
  • 245 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2023.

Based on Covenant Asset Management's 13F filing for Q2 2023, filed 12 Jul 2023.